中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共4条，第1-4条

帮助

条数/页：排序方式：
	Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 期刊论文 OAI收割 EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897 作者: Lu, Tingting; Cao, Jiangyan; Zou, Fengming; Li, Xixiang; Wang, Aoli \| 收藏 \| 浏览/下载：57/0 \| 提交时间：2021/04/26 BCR-ABL ABL mutants Chronic myeloid leukemia Kinase inhibitor Imatinib resistance
	Y-632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo 期刊论文 OAI收割 CANCER SCIENCE, 2016, 卷号: 107, 期号: 6, 页码: 782-790 作者: Wang, Wenqian; Liu, Yang; Zhao, Zhixin; Xie, Chengying; Xu, Yongping \| 收藏 \| 浏览/下载：25/0 \| 提交时间：2019/01/08 Hop Hsp90 imatinib resistance thiol oxidation Y-632
	Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2014, 卷号: 35, 期号: 3, 页码: 401-409 作者: Wu, Li-xian; Wu, Ying; Chen, Rui-jia; Liu, Yang; Huang, Li-sen \| 收藏 \| 浏览/下载：25/0 \| 提交时间：2019/01/08 chronic myelogenous leukemia imatinib resistance Bcr-Abl mutantion curcumin C817 leukemia stem cell
	Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants 期刊论文 OAI收割 CANCER SCIENCE, 2014, 卷号: 105, 期号: 1, 页码: 117-125 作者: Zhao, Jie; Quan, Haitian; Xu, Yongping; Kong, Xiangqian; Jin, Lu \| 收藏 \| 浏览/下载：34/0 \| 提交时间：2019/01/08 Drug resistance flumatinib gastrointestinal stromal tumors imatinib mesylate sunitinib malate